Molecular breast imaging (MBI) has proven a useful secondary screening tool for women with dense breasts when routinely deployed at a large, community-based breast imaging center. 

Digital mammography combined with digital breast tomosynthesis is better than digital mammography alone at finding cancers and reducing recall rates. But another combo has now proven just as good at detection, better at cutting recalls and especially impressive at reducing radiation dose. 

When the 2016 Paralympic Games roll into Rio next month, clinicians caring for the athletes will have at their disposal MRI, ultrasound and digital x-ray equipment courtesy of GE.

In locales and cultures as far removed from one another as Ethiopia and Pennsylvania, trainee radiologists finely—and similarly—honed their technical skills in pediatric ultrasound after viewing brief web-based tutorials on image acquisition.

Mallinckrodt Pharmaceuticals announced Aug. 24 it has reached an agreement to sell its nuclear imaging business to IBA Molecular (IBAM) for $690 million.

It’s rare to see radiological research making national front-page news. But the Zika virus has emerged as a top enemy of the national health, and RSNA’s Radiology has published some heart-stopping images inside a free study that went up Aug. 23 on the journal’s website.

Average-risk women with low breast density who get screened for breast cancer every three years share a trait in common with higher-risk women with high breast density who get screened every year. Both groups will maintain a similar or better balance of benefits and harms than average-risk women who get screened every other year.

An innovative use of RNA sequences has allowed scientists from Cold Spring Harbor Laboratory to track connections between individual neurons in the brain, according to a study published in Neuron. Invented by Professor Anthony Zador, MD, PhD, the technique is called Multiplexed Analysis of Projections by Sequencing (MAPseq).